| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Breast cancer stage at diagnosis: Caucasians versus Hispanics
|
Arlene J. Zaloznik
|
|
1997
|
42 |
2 |
p. 121-124
4 p.
|
artikel
|
| 2 |
Breast cancer stage at diagnosis: Caucasians versus Hispanics
|
Zaloznik, Arlene J.
|
|
1997
|
42 |
2 |
p. 121-124
|
artikel
|
| 3 |
CeReS-18, a novel cell surface sialoglycopeptide, induces cellcycle arrest and apoptosis in a calcium-sensitive manner
|
Natalie A. Betz
|
|
1997
|
42 |
2 |
p. 137-148
12 p.
|
artikel
|
| 4 |
CeReS-18, a novel cell surface sialoglycopeptide, induces cell cycle arrest and apoptosis in a calcium-sensitive manner
|
Betz, Natalie A.
|
|
1997
|
42 |
2 |
p. 137-148
|
artikel
|
| 5 |
Clinical significance of bcl-2 gene expression in human breastcancer tissues
|
Shunzo Kobayashi
|
|
1997
|
42 |
2 |
p. 173-181
9 p.
|
artikel
|
| 6 |
Clinical significance of bcl-2 gene expression in human breast cancer tissues
|
Kobayashi, Shunzo
|
|
1997
|
42 |
2 |
p. 173-181
|
artikel
|
| 7 |
Influence of investigator experience and microscopic fieldsize on microvessel density in node-negative breast carcinoma
|
Peter B. Vermeulen
|
|
1997
|
42 |
2 |
p. 165-172
8 p.
|
artikel
|
| 8 |
Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma
|
Vermeulen, Peter B.
|
|
1997
|
42 |
2 |
p. 165-172
|
artikel
|
| 9 |
Inhibition of hormone and growth factor responsive andresistant human breast cancer cells by CeReS-18, acell regulatory sialoglycopeptide
|
Heideh K. Fattaey
|
|
1997
|
42 |
2 |
p. 125-136
12 p.
|
artikel
|
| 10 |
Inhibition of hormone and growth factor responsive and resistant human breast cancer cells by CeReS-18, a cell regulatory sialoglycopeptide
|
Fattaey, Heideh K.
|
|
1997
|
42 |
2 |
p. 125-136
|
artikel
|
| 11 |
Macromolecular interstitial clearance, tumour vascularity,other prognostic factors and breast cancer survival
|
Ernest E. Sterns
|
|
1997
|
42 |
2 |
p. 113-120
8 p.
|
artikel
|
| 12 |
Macromolecular interstitial clearance, tumour vascularity, other prognostic factors and breast cancer survival
|
Sterns, Ernest E.
|
|
1997
|
42 |
2 |
p. 113-120
|
artikel
|
| 13 |
Modulation by lonidamine on the combined activity ofcisplatin and epidoxorubicin in human breast cancer cells
|
Rosella Silvestrini
|
|
1997
|
42 |
2 |
p. 103-112
10 p.
|
artikel
|
| 14 |
Modulation by lonidamine on the combined activity of cisplatin and epidoxorubicin in human breast cancer cells
|
Silvestrini, Rosella
|
|
1997
|
42 |
2 |
p. 103-112
|
artikel
|
| 15 |
Phase II study of vinorelbine and ifosfamide inanthtracycline resistent metastatic breast cancer
|
P. Pronzato
|
|
1997
|
42 |
2 |
p. 183-186
4 p.
|
artikel
|
| 16 |
Phase II study of vinorelbine and ifosfamide in anthtracycline resistent metastatic breast cancer
|
Pronzato, P.
|
|
1997
|
42 |
2 |
p. 183-186
|
artikel
|
| 17 |
Seasonal trends in the self-detection of breast cancer:indications from the Cancer and Steroid Hormone (CASH) study
|
Julie A. Ross
|
|
1997
|
42 |
2 |
p. 187-192
6 p.
|
artikel
|
| 18 |
Seasonal trends in the self-detection of breast cancer: indications from the Cancer and Steroid Hormone (CASH) study
|
Ross, Julie A.
|
|
1997
|
42 |
2 |
p. 187-192
|
artikel
|
| 19 |
TGF-1 mRNA expression in clinical breast cancer andits relationship to ER mRNA expression
|
K.D. Amoils
|
|
1997
|
42 |
2 |
p. 95-101
7 p.
|
artikel
|
| 20 |
TGF-β1 mRNA expression in clinical breast cancer and its relationship to ER mRNA expression
|
Amoils, K.D.
|
|
1997
|
42 |
2 |
p. 95-101
|
artikel
|
| 21 |
Validation of existing and development of new prognosticclassification schemes in node negative breast cancer
|
Willi Sauerbrei
|
|
1997
|
42 |
2 |
p. 149-163
15 p.
|
artikel
|
| 22 |
Validation of existing and development of new prognostic classification schemes in node negative breast cancer
|
Sauerbrei, Willi
|
|
1997
|
42 |
2 |
p. 149-163
|
artikel
|
Tijdschrift beschrijving